Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.77 - $4.63 $151,133 - $252,617
-54,561 Reduced 84.49%
10,015 $28,000
Q1 2024

May 15, 2024

SELL
$4.02 - $5.39 $11,790 - $15,808
-2,933 Reduced 4.34%
64,576 $273,000
Q4 2023

Feb 14, 2024

SELL
$4.0 - $5.49 $60,912 - $83,601
-15,228 Reduced 18.41%
67,509 $361,000
Q3 2023

Nov 16, 2023

SELL
$4.0 - $5.82 $59,608 - $86,729
-14,902 Reduced 15.26%
82,737 $355,000
Q2 2023

Aug 14, 2023

SELL
$4.19 - $6.16 $90,629 - $133,240
-21,630 Reduced 18.14%
97,639 $536,000
Q1 2023

May 15, 2023

SELL
$2.45 - $4.22 $45,141 - $77,753
-18,425 Reduced 13.38%
119,269 $500,000
Q4 2022

Feb 14, 2023

SELL
$2.12 - $2.86 $265,661 - $358,392
-125,312 Reduced 47.65%
137,694 $381,000
Q3 2022

Nov 15, 2022

BUY
$2.33 - $3.92 $612,803 - $1.03 Million
263,006 New
263,006 $673,000
Q1 2021

May 17, 2021

SELL
$3.91 - $6.99 $277,844 - $496,709
-71,060 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$3.0 - $4.5 $16,281 - $24,421
5,427 Added 8.27%
71,060 $305,000
Q3 2020

Nov 16, 2020

SELL
$2.75 - $4.2 $8,024 - $12,255
-2,918 Reduced 4.26%
65,633 $198,000
Q2 2020

Aug 17, 2020

BUY
$2.12 - $3.14 $145,328 - $215,250
68,551 New
68,551 $213,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $90.4M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.